Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-2,745
Closed -$207K 220
2026
Q1
$207K Hold
2,745
0.01% 197
2025
Q4
$204K Buy
+2,745
New +$201K 0.01% 196
2024
Q4
Sell
-2,745
Closed -$224K 195
2024
Q3
$224K Hold
2,745
0.01% 183
2024
Q2
$204K Hold
2,745
0.01% 186
2024
Q1
$214K Buy
+2,745
New +$204K 0.01% 156
2023
Q3
Sell
-2,745
Closed -$222K 154
2023
Q2
$222K Hold
2,745
0.01% 147
2023
Q1
$222K Hold
2,745
0.01% 150
2022
Q4
$205K Buy
+2,745
New +$195K 0.01% 155
2022
Q3
Sell
-3,509
Closed -$243K 156
2022
Q2
$243K Hold
3,509
0.01% 145
2022
Q1
$270K Hold
3,509
0.01% 136
2021
Q4
$269K Hold
3,509
0.02% 137
2021
Q3
$259K Hold
3,509
0.02% 137
2021
Q2
$234K Hold
3,509
0.01% 148
2021
Q1
$261K Sell
3,509
-311
-8% -$23.6K 0.02% 120
2020
Q4
$278K Sell
3,820
-144
-4% -$10.2K 0.02% 120
2020
Q3
$263K Hold
3,964
0.02% 112
2020
Q2
$226K Buy
+3,964
New +$194K 0.02% 116
2020
Q1
Sell
-3,964
Closed -$207K 126
2019
Q4
$207K Hold
3,964
0.02% 134
2019
Q3
$200K Buy
+3,964
New +$195K 0.02% 127

Other funds holding HOLX

Sand Hill Global Advisors's HOLX Position: Q2 2026 in Review

Sand Hill Global Advisors sold out of Hologic (HOLX) in Q2 2026, closing a stake of 2,745 shares — an estimated $207K sold.

Sand Hill Global Advisors first reported a position in HOLX in Q3 2019 and held it in 19 quarters. The position peaked at $278K in Q4 2020. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

  • Sand Hill Global Advisors reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
  • Sand Hill Global Advisors sold 2,745 Hologic shares in Q2 2026, an estimated $207K.
  • Sand Hill Global Advisors first reported a position in Hologic in Q3 2019 and held it in 19 quarters.
  • Sand Hill Global Advisors's Hologic position peaked at $278K in Q4 2020.
  • 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on Sand Hill Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.